Diagnostic and therapeutic algorithm for colorectal peritoneal metastases. A consensus of the peritoneal surface malignancies onco-team of the Italian society of surgical oncology.


Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
01 2021
Historique:
received: 22 07 2020
revised: 04 09 2020
accepted: 26 09 2020
pubmed: 9 10 2020
medline: 21 4 2021
entrez: 8 10 2020
Statut: ppublish

Résumé

the surgical workup for colorectal cancer peritoneal metastases (CRCPM) is complex and should be managed in specialized centers. Diagnostic and therapeutic algorithms (DTA) have been proposed to balance optimal patients management and correct use of resources. Aim of this study was to establish a consensus on DTA for CRCPM patients in Italy. a panel of 18 delegated members of centers afferent to Peritoneal Surface Malignancies Onco-team of the Italian Society of Surgical Oncology was established. A list of statements regarding the DTA of patients with CRCPM was prepared according to different activities and decision-making nodes with a defined entry and exit point. Consensus was obtained through RAND UCLA methodology. two different DTA were defined and approved according to the modality of presentation of CRCPM (synchronous and metachronous). A consensus was also obtained on 17 of the 19 statements related to DTA. a shared model of DTA is now available for healthcare providers to monitor appropriateness in diagnosis and treatment of patients with isolated peritoneal metastases from CRC.

Identifiants

pubmed: 33028502
pii: S0748-7983(20)30807-6
doi: 10.1016/j.ejso.2020.09.035
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

164-171

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest None of the authors have any conflicts of interest.

Auteurs

Antonio Sommariva (A)

Unit of Surgical Oncology of the Esophagus and Digestive Tract, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.

Luca Ansaloni (L)

Unit of General and Emergency Surgery, Bufalini Hospital, Cesena, Italy.

Gian Luca Baiocchi (GL)

Department of Clinical and Experimental Sciences, University of Brescia, Italy.

Stefano Cascinu (S)

Department of Medical Oncology Vita-Salute, San Raffaele University IRCCS, Milan, Italy.

Roberto Cirocchi (R)

General Surgery and Clinical Anatomy, University of Perugia, Perugia, Italy.

Federico Coccolini (F)

Department of Surgery, Pisa University Hospital, Pisa, Italy.

Marcello Deraco (M)

Peritoneal Surface Malignancies Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: Marcello.Deraco@istitutotumori.mi.it.

Gianmaria Fiorentini (G)

Department of Onco-Hematology, Azienda Ospedaliera 'Ospedali Riuniti Marche Nord', Pesaro, Italy.

Roberta Gelmini (R)

General and Oncological Surgery Unit, AOU of Modena University of Modena and Reggio Emilia, Italy.

Andrea Di Giorgio (A)

Surgical Unit of Peritoneum and Retroperitoneum, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.

Piero Vincenzo Lippolis (PV)

Chirurgia Generale e Peritoneale Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Enrico Maria Pasqual (EM)

Advanced Surgical Oncology Unit, Department Area Medica, University of Udine, Italy.

Cinzia Sassaroli (C)

Abdominal Oncology Department, Fondazione Giovanni Pascale, IRCCS, Naples, Italy.

Antonio Macrì (A)

Department of Human Pathology, Peritoneal Surface Malignancy and Soft Tissue Sarcoma Program, University of Messina, Italy.

Paolo Sammartino (P)

Department of Surgery 'P. Valdoni', Sapienza University of Rome, Rome, Italy.

Stefano Scaringi (S)

Digestive Surgery Unit - IBD Unit, Careggi University Hospital, Florence, Italy.

Mario Valle (M)

Surgical Oncology Peritoneum and Abdomen Pathologies, National Cancer Institute "Regina Elena" Rome, Italy.

Marco Vaira (M)

Unit of Surgical Oncology, Candiolo Cancer Institute, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH